Table V.
Frequency of Reported Adverse Events by Treatment (42 Events Reported)
| Adverse Event | Atenolol | Metoprolol a |
|---|---|---|
| Upper respiratory infection | 4 | 4 |
| Fatigue | 5 | 3 |
| Headaches | 2 | 1 |
| Dizziness | 2 | 2 |
| Rash | 2 | 0 |
| Perspiration | 0 | 2 |
| Dyspnea | 0 | 2 |
| Blurred vision | 2 | 0 |
| Urinary tract infection | 0 | 2 |
| Vomiting | 1 | 0 |
| Sexual dysfunction | 1 | 0 |
| Muscle cramps | 1 | 0 |
| Muscle aches | 0 | 1 |
| Minor chest pain | 0 | 1 |
| Diarrhea | 1 | 0 |
| Edema | 0 | 1 |
| Irregular heart rate | 1 | 0 |
| Gastrointestinal symptoms | 0 | 1 |
| aThe preparation of extended‐release metoprolol succinate was used. Note: One participant in the metoprolol group experienced a severe adverse event (hospitalized for shortness of breath). | ||